BioUtah News
-
Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer
Spectrum Solutions, LLC on January 27 announced it is sponsoring research in collaboration with the UCLA School of…
-
Entrepreneur Your Startup – Get a Master’s Degree
Calling all life sciences early stage founders and startups! In partnership with the Lassonde Entrepreneur Institute at the…
-
SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in…
-
Science and Safety of the COVID-19 Vaccine (January 15, 2021)
Presented by BioUtah and the Salt Lake Chamber on January 15, 2021, this webinar provided a briefing with biopharmaceutical…
-
Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products
Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly…
-
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited; Provides Corporate Update
Clene Nanomedicine, Inc. (Clene) last week announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”)…
-
Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita
Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression…
-
Early Vaccination Available for Some Life Science Industry Employees
We’ve received more information on channels for vaccine distribution with some positive developments
-
Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer™ Platform
Co-Diagnostics has announced that it has completed principal design work for a PCR test that would allow researchers…
-
Vertex Announces FDA Approvals for Expanded Use of Cystic Fibrosis Medicines
Vertex has announced FDA approval of eligibility for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include people with cystic fibrosis (CF)…
-
Phoenix PharmaLabs Announces New Investment Offering with Netcapital
Phoenix PharmaLabs (Phoenix), a Utah company developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced…
-
State of Utah Announces Updated Plans for Vaccine Distribution
Today the State of Utah released updated plans for First Wave of Phase 2 COVID-19 Vaccine Distribution. Notably…
-
Medsential Offering an FDA EUA Approved COVID Point of Care Antibody Rapid Test
Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers…
-
ELITech’s COVID, Flu, RSV Multiplex Test Receives CE Mark
ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The…
-
SDP Oncology Presents Data Evaluating Alvocidib in Patients with Acute Myeloid Leukemia and Other Updates on Development Programs at ASH 2020
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new data from the Phase 2 Zella 201 study…
-
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in the Dubermatinib Arm of The Leukemia & Lymphoma Society’s Beat AML Master Clinical Trial in Patients with Acute Myeloid Leukemia
Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been…
-
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 2 of Cancer Study
Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been…
-
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test
Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing…
-
Utah COVID-19 Small Business Quarantined Employee Grants
Utah continues to support the business community during the COVID-19 pandemic with its COVID-19 Small Business Quarantined Employee…
-
Braveheart Brings Healthcare to India’s Last Mile Community
These days we can all use uplifting news, so please check out this short story about how BraveHeart…
-
Representative McAdams Honored with the 2020 Champion of Health Care Innovation Award
In a virtual December 3 ceremony, the American Life Sciences Innovation Council (ALSIC), BioUtah and several state and…
-
Utah Life Sciences Leaders Honored At 2020 Virtual Life Sciences Summit
On the last day of the Summit, BioUtah announced its 2020 Utah Life Sciences award winners, which were presented during…
-
Quansys Biosciences Receives EUA for COVID-19 Antibody Test, Provides Exceptional Clinical Performance
Quansys Biosciences has received emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test…
-
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
-
BioHive Launched at Utah Life Sciences Summit – Join the Campaign
The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the…
-
Transit Scientifc’s New Angioplasty System Dilates Calcified & Fibrotic Vessels
Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific…
-
Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal
Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement…
-
IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections
Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse…
-
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
-
Governor Herbert Announces New COVID-19 Transmission Index
On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan…
-
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors
CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today…
-
SINTX Technologies Develops New Mask Fabric with Silicon Nitride
On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory…
-
Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor
Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical…
-
U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology
U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners…
-
Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives
Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized…
-
Foldax Named Finalist in the Fierce Innovation Awards
Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020,…
-
Alucent Biomedical Announces $35 Million Series B Financing
Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is…
-
IONIQ Sciences’ ProLung Test Accepted for Submission to China’s National Medical Products Administration
IONIQ Sciences, based in Salt Lake City, and a BioUtah member, announced September 20 that its IONIQ ProLung…
-
SDP Oncology Announces New Data from Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase…
-
RenalytixAI Receives California Commercial Lab Certification
RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
